等待开盘 03-26 09:30:00 美东时间
+1.180
+7.77%
今日重点评级关注:HC Wainwright & Co.:维持Perspective Therapeutics"买入"评级,目标价从12美元升至13美元;Litchfield Hills:维持Star Equity Holdings"买入"评级,目标价从21美元升至28美元
03-24 10:07
Barclays analyst Eliana Merle maintains uniQure (NASDAQ:QURE) with a Equal-Weight and lowers the price target from $31 to $25.
03-23 22:17
今日重点评级关注:LUCID CAPITAL MARKETS:上调INmune Bio评级至"买入" 目标价从2美元升至9美元;Clear Street:维持MoonLake Immunotherapeutics Class A"买入"评级,目标价从45美元升至70美元
03-12 12:34
Top Wall Street analysts changed their outlook on top names. See all changes on analyst ratings page.
03-11 20:19
Mizuho analyst Uy Ear upgrades uniQure (NASDAQ:QURE) from Neutral to Outperform and raises the price target from $12 to $35.
03-11 17:49
医药股齐升!Xenon制药飙升近50%,癫痫新药临床试验获重大突破;HIMS大涨40%,获诺和诺德授权销售其减肥药;QURE大涨26%,FDA疫苗负责人将离职,有分析称监管政策或转向灵活>>
03-10 16:46
今日重点评级关注:Evercore ISI集团:维持Caribou Biosciences"跑赢大市"评级,目标价从11美元升至13美元;富国银行:上调uniQure评级至"超配",目标价从15美元升至60美元
03-10 15:05
Despite a US FDA official criticizing uniQure (QURE) on March 5 for the way it conducted a study for Huntington's disease asset AMT-130, the stock is surging ~36% in premarket trading Monday. That off...
03-09 21:01
(来源:invest wallstreet) uniQure BV (NASDAQ:QURE)股价周一飙升36%,此前有报道称美国食品药品监督管理局疫苗和基因治...
03-09 20:41
Gainers Relmada Therapeutics (NASDAQ:RLMD) stock rose 48.3% to $6.6 during Mon...
03-09 20:05